Management of Pain Associated With Failed Back Surgery Syndrome
NCT ID: NCT05324761
Last Updated: 2023-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2022-04-25
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
our study aims to evaluate the efficacy of Pregabalin and Gabapentin in the management of this condition and to compare between them
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Gabapentin and Pregabalin for Radicular Pain
NCT02064790
Effect of Preoperative Oral Pregabalin Versus Intraoperative Fentanyl on Postoperative Analgesia
NCT05150795
Efficacy of Pregabalin in Patients With Radicular Pain
NCT00908375
Efficacy of Pregabalin Versus Combined Pregabalin and Milnacipran in Fibromyalgia.
NCT03905486
To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.
NCT00141375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregabalin
A dose of 75 mg of Pregabalin twice daily for one month will be prescribed to each patient enrolled this study arm
Pregabalin 75mg
Each patient complaining of pain associated with spine surgery who is randomly enrolled this arm of the study and start the specific medication of the arm with the recommended dose and duration for a period of one month, patient will be followed regularly regarding compliance to doses and to register any side effect.
Gabapentin
A dose of 300 mg of Gabapentin twice daily for one month will be prescribed to each patient enrolled this study arm
Gabapentin 300mg
Each patient complaining of pain associated with spine surgery who is randomly enrolled this arm of the study and start the specific medication of the arm with the recommended dose and duration for a period of one month, patient will be followed regularly regarding compliance to doses and to register any side effect.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pregabalin 75mg
Each patient complaining of pain associated with spine surgery who is randomly enrolled this arm of the study and start the specific medication of the arm with the recommended dose and duration for a period of one month, patient will be followed regularly regarding compliance to doses and to register any side effect.
Gabapentin 300mg
Each patient complaining of pain associated with spine surgery who is randomly enrolled this arm of the study and start the specific medication of the arm with the recommended dose and duration for a period of one month, patient will be followed regularly regarding compliance to doses and to register any side effect.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with psychiatric illnesses
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Kindy College of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laith Thamer Al-Ameri
assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laith Al-Ameri
Role: STUDY_DIRECTOR
University of Baghdad - Al-Kindy College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laith Thamer Al-Ameri
Baghdad, , Iraq
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13 Al-KindyCM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.